Dose-Finding Study of Intranasal Insulin in Healthy Participants Insulin in Healthy Participants
Status:
Recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
This study is to determine the safety and tolerability of regular insulin (Humulin R) when
given intranasally (as drops in nostrils).
Healthy participants will be enrolled to determine the maximum tolerated dose of intranasal
insulin.